Skip to main content
  • Notice of Privacy Incident
  • Medicaid Provider Termination Alert: Revalidation deadlines are approaching. Failure by providers to revalidate will lead to termination and payment suspension. Check your account now at https://impact.illinois.gov/ to learn if your required revalidation is due this month. More revalidation information here.
Elizabeth M. Whitehorn, Director

Drugs and Therapeutics (D & T) Committee Meeting Results for: March 9, 2011

Drug Name Review Type Committee Recommendation Prior Approval Status � Final Determination
Pradaxa New Drug Initial Review Remove Prior Approval Requirement Prior Approval Required
Veregan New Drug Initial Review Remove Prior Approval Requirement Prior Approval Required
Latuda New Drug Initial Review Remove Prior Approval Requirement Prior Approval Required
Kapvay New Drug Initial Review Require Prior Approval Prior Approval Required
Fanapt New Drug Initial Review Remove Prior Approval Requirement Prior Approval Required
Pegasys PDL Appeal Remove Prior Approval Requirement Prior Approval Requirement Removed